|
|
|
|
|
| Available: 0 |
| List Price:$109.00 |
|
Other formats:
|
| Edition: | 1st |
| Publisher: | Springer Nature |
| ISBN: | 3-319-33197-3 (3319331973) |
| ISBN-13: | 978-3-319-33197-3 (9783319331973) |
| New Edition: | 3-030-71912-X |
| Binding: | Hardcover |
| Copyright: | 2016 |
| Publish Date: | 08/16 |
| Volume: | 2016 |
| Weight: | 0.00 Lbs. |
| Pages: | 272 |
| Subject Class: | ONC (Oncology) |
| Remarks: | A New Edition of this Title is Available |
| Return Policy: | Returns accepted up to 12 months provided no other recalls or return restrictions apply. |
| ProQuest Ebook Central: |
Available in ProQuest Ebook Central™ View
|
|
|
| |
| ISSN Series: | Hematologic Malignancies | | Abstract: | This book provides state-of-the-art reviews of key issues and recent developments relating to chronic myeloid leukemia (CML), acquainting the reader with advances in research, treatment, and promotion of public health. Among the management topics addressed are the choices, advantages, and pitfalls of first-, second-, and third-line treatments; the European LeukemiaNet recommendations; management of adverse effects of tyrosine kinase inhibitors (TKI); management of CML blast crisis; management of pregnancy in the context of CML; the role of hematopoietic cell transplantation; the current experience with TKI discontinuation; and the value of interferon in improving the outcome of TKI treatment. Various aspects of relevance to treatment outcome are discussed, including prognostic scores, molecular monitoring (principles and interlaboratory standardization), and response-related predictors of survival. Furthermore, updates are provided on the increasing prevalence of CML and its implications and on the changing cost of care for CML, taking into account the forthcoming impact of availability of generic imatinib. |
|
|
|
|
|
|
Follow Matthews Book Co. on:
Copyright © 2001-2024 Matthews Book Company - All rights reserved. - 11559 Rock Island Ct., Maryland Heights, MO, 63043 - (800) MED-BOOK
Matthews